JEAN LEVIN: Open Payments
NPI 1881794089 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,832 in 100 payments from 29 companies in 2025. Trend: 2023 $3,329 · 2024 $7,130 · 2025 $1,832
Food & beverage: $1,809Education: $23
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $258 |
| ABBVIE INC. | 11 | $193 |
| Incyte Corporation | 10 | $153 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| Genentech USA, Inc. | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Janssen Biotech, Inc. | 4 | $80 |
| PFIZER INC. | 4 | $63 |
| Exelixis Inc. | 3 | $57 |
Products named: Enhertu, JAKAFI, KEYTRUDA, OJJAARA, ELAHERE, RYBREVANT, EMRELIS, CABOMETYX.
Industry payments across PA — which companies pay providers there.
